Table 4.
Outcome | Rate of change per year during lymphedema management study (1995–1998) | P | Rate of change per year post-lymphedema management study (2000–2008) | P |
---|---|---|---|---|
Foot circumference† | –0.23 | < 0.01 | –0.12 | 0.10 |
Ankle circumference‡ | –0.37 | 0.01 | –0.18 | 0.23 |
Leg circumference§ | –0.20 | 0.18 | –0.13 | 0.46 |
Volume displacement¶ | 45.01 | 0.07 | 56.69 | 0.02 |
ADL episodes# | 0.59 | < 0.01 | 1.28 | < 0.01 |
Adjusted for the same model specific variables as the mass drug administration models by using a generalized estimating equations (GEEs) repeated measures linear regression unless noted otherwise below. ADL = adenolymphangitis.
Circumference (in cm) of the foot 10 cm from the tip of the first toe.
Circumference (in cm) of the ankle 10 cm from the floor.
Circumference (in cm) of the ankle 25 cm from the floor.
Amount of water (in mL) displaced from a standard volume of water.
Rate of change reported is a rate ratio using a GEE repeated measures Poisson regression model. Rate defined as the number of ADL episodes per year.